1887

Abstract

BK polyomavirus (BKPyV) quantitative testing is an important screening tool post-transplantation, although interpretation can be challenging due to lack of standardization, assay heterogeneity and variability of BKPyV DNA over time (in urine).

Remnant clinical EDTA plasma and urine samples were tested by the cobas BKV test and a validated laboratory-developed test (LDT). Accuracy [positive and negative percent agreement (PPA and NPA), Pearson’s correlation, Bland–Altman analysis] and reproducibility were evaluated. To assess BKPyV DNA stability in urine, prospective urine samples were maintained at two different storage temperatures and tested in triplicate over 7 days.

Overall PPA was 95.6 % (43/45) and NPA was 94.4 % (170/180). For plasma, Pearson’s correlation (0.950) and Bland–Altman analysis (0.113±0.22 log IU ml) showed high agreement. For neat urine, Pearson’s correlation (0.842) and Bland–Altman analysis (0.326±0.80 log IU ml) showed somewhat higher variability. Reproducibility was high for the cobas BKV versus the LDT. BKPyV DNA levels in neat urine remained relatively stable over 7 days at both storage temperatures, although outlier results were intermittently detected.

The cobas BKV test showed high agreement and reproducibility compared to the reference LDT. BKPyV viral load testing in urine has known limitations, but neat urine can be processed by the cobas BKV.

Keyword(s): BKV , stability , transplantation , urine and viral load
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001789
2024-01-24
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/73/1/jmm001789.html?itemId=/content/journal/jmm/10.1099/jmm.0.001789&mimeType=html&fmt=ahah

References

  1. Imlay H, Baum P, Brennan DC, Hanson KE, Hodges MR et al. Consensus definitions of BK polyomavirus nephropathy in renal transplant recipients for Clinical Trials. Clin Infect Dis 2022; 75:1210–1216 [View Article] [PubMed]
    [Google Scholar]
  2. Hirsch HH, Randhawa PS. AST Infectious Diseases Community of Practice BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33:e13528 [View Article] [PubMed]
    [Google Scholar]
  3. Hayden RT, Su Y, Boonyaratanakornkit J, Cook L, Gu Z et al. Matrix matters: assessment of commutability among BK virus assays and standards. J Clin Microbiol 2022; 60:e0055522 [View Article] [PubMed]
    [Google Scholar]
  4. Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E et al. Sequence variation in amplification target genes and standards influences interlaboratory comparison of BK virus DNA load measurement. J Clin Microbiol 2015; 53:3842–3852 [View Article] [PubMed]
    [Google Scholar]
  5. Govind S, Hockley J, Morris C, Almond N. Collaborative Study Group The development and establishment of the 1st WHO BKV International Standard for nucleic acid based techniques. Biologicals 2019; 60:75–84 [View Article] [PubMed]
    [Google Scholar]
  6. Whiley DM, Mackay IM, Sloots TP. Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol 2001; 39:4357–4361 [View Article] [PubMed]
    [Google Scholar]
  7. Palavecino EL, Ridley T, Hester L, Blosser SJ. Analytical evaluation of the cobas® 6800 system for the detection and quantification of BK Virus (BKV) and Epstein Barr Virus (EBV) at a US solid organ and hematopoietic stem cell transplant center. Diagn Microbiol Infect Dis 2023; 105:115884 [View Article] [PubMed]
    [Google Scholar]
  8. Boan P, Hewison C, Swaminathan R, Irish A, Warr K et al. Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy. BMC Infect Dis 2016; 16:342 [View Article] [PubMed]
    [Google Scholar]
  9. Albrecht P, Erler J, Baumann N, Lütgehetmann M, Baum P et al. Variation of BKV DNA quantitation in neat and stabilized urine due to target inhomogeneity. Transplantation 2020; 104:S331 [View Article]
    [Google Scholar]
  10. Song J, Kim S, Kwak E, Park Y. Evaluating the efficiency of the Cobas 6800 system for BK virus detection in plasma and urine samples. Diagnostics (Basel) 2023; 13:2860 [View Article] [PubMed]
    [Google Scholar]
  11. Nickeleit V, Singh HK. Polyomaviruses and disease: is there more to know than viremia and viruria?. Curr Opin Organ Transplant 2015; 20:348–358 [View Article] [PubMed]
    [Google Scholar]
  12. cobas® BKV Quantitative nucleic acid test for use on the cobas® 6800/8800 Systems. n.d https://diagnostics.roche.com/global/en/products/params/cobas-bkv.html accessed 30 August 2023
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001789
Loading
/content/journal/jmm/10.1099/jmm.0.001789
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error